UnitedHealth Group Incorporated (UNH) Position Held by Fortaleza Asset Management Inc.

Fortaleza Asset Management Inc. held its stake in UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 2,070 shares of the healthcare conglomerate’s stock at the close of the second quarter. Fortaleza Asset Management Inc.’s holdings in UnitedHealth Group were worth $384,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Waldron LP grew its holdings in shares of UnitedHealth Group by 153.1% during the first quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock worth $944,000 after buying an additional 3,487 shares in the last quarter. Nwam LLC grew its holdings in shares of UnitedHealth Group by 1.2% during the first quarter. Nwam LLC now owns 2,683 shares of the healthcare conglomerate’s stock worth $440,000 after buying an additional 32 shares in the last quarter. Wrapmanager Inc. grew its holdings in shares of UnitedHealth Group by 1.0% during the first quarter. Wrapmanager Inc. now owns 16,265 shares of the healthcare conglomerate’s stock worth $2,668,000 after buying an additional 154 shares in the last quarter. Jackson Grant Investment Advisers Inc. grew its holdings in shares of UnitedHealth Group by 0.4% during the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares in the last quarter. Finally, 361 Capital LLC grew its holdings in shares of UnitedHealth Group by 18.2% during the first quarter. 361 Capital LLC now owns 26,323 shares of the healthcare conglomerate’s stock worth $4,317,000 after buying an additional 4,046 shares in the last quarter. Institutional investors own 86.11% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://transcriptdaily.com/2017/10/23/unitedhealth-group-incorporated-unh-position-held-by-fortaleza-asset-management-inc.html.

Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 207.49 on Monday. UnitedHealth Group Incorporated has a 1-year low of $136.22 and a 1-year high of $208.21. The company has a market cap of $205.21 billion, a price-to-earnings ratio of 23.56 and a beta of 0.63. The firm’s 50-day moving average is $197.42 and its 200 day moving average is $185.93.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the business earned $2.17 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post $9.96 EPS for the current fiscal year.

UNH has been the subject of a number of recent research reports. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, June 28th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reiterated an “outperform” rating and set a $190.00 price target on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Deutsche Bank AG lifted their price target on shares of UnitedHealth Group from $187.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, July 13th. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $215.27.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 77,149 shares of company stock valued at $15,182,242. 0.89% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply